Cynthia Schwalm - Net Worth and Insider Trading
Cynthia Schwalm Net Worth
The estimated net worth of Cynthia Schwalm is at least $305,225 dollars as of 2024-11-13. Cynthia Schwalm is the Director of Kadmon Holdings Inc and owns about 31,000 shares of Kadmon Holdings Inc (KDMN) stock worth over $294,500. Cynthia Schwalm is also the Director of G1 Therapeutics Inc and owns about 1,500 shares of G1 Therapeutics Inc (GTHX) stock worth over $10,725. Details can be seen in Cynthia Schwalm's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cynthia Schwalm has not made any transactions after 2020-03-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cynthia Schwalm
Cynthia Schwalm Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cynthia Schwalm owns 3 companies in total, including G1 Therapeutics Inc (GTHX) , Kadmon Holdings Inc (KDMN) , and Lisata Therapeutics Inc (LSTA) .
Click here to see the complete history of Cynthia Schwalm’s form 4 insider trades.
Insider Ownership Summary of Cynthia Schwalm
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2018-12-26 | director |
| KDMN | Kadmon Holdings Inc | 2020-05-13 | director |
| LSTA | Lisata Therapeutics Inc | 2018-11-07 | director |
Cynthia Schwalm Latest Holdings Summary
Cynthia Schwalm currently owns a total of 2 stocks. Among these stocks, Cynthia Schwalm owns 31,000 shares of Kadmon Holdings Inc (KDMN) as of March 12, 2020, with a value of $294,500 and a weighting of 96.49%. Cynthia Schwalm also owns 1,500 shares of G1 Therapeutics Inc (GTHX) as of December 26, 2018, with a value of $10,725 and a weighting of 3.51%.
Latest Holdings of Cynthia Schwalm
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KDMN | Kadmon Holdings Inc | 2020-03-12 | 31,000 | 9.50 | 294,500 |
| GTHX | G1 Therapeutics Inc | 2018-12-26 | 1,500 | 7.15 | 10,725 |
Holding Weightings of Cynthia Schwalm
Cynthia Schwalm Form 4 Trading Tracker
According to the SEC Form 4 filings, Cynthia Schwalm has made a total of 1 transactions in Kadmon Holdings Inc (KDMN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kadmon Holdings Inc is the acquisition of 31,000 shares on March 12, 2020, which cost Cynthia Schwalm around $100,440.
According to the SEC Form 4 filings, Cynthia Schwalm has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the acquisition of 1,420 shares on December 26, 2018, which cost Cynthia Schwalm around $26,199.
Insider Trading History of Cynthia Schwalm
- 1
Cynthia Schwalm Trading Performance
GuruFocus tracks the stock performance after each of Cynthia Schwalm's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cynthia Schwalm is 13.12%. GuruFocus also compares Cynthia Schwalm's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cynthia Schwalm within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cynthia Schwalm's insider trading performs compared to the benchmark.
Performance of Cynthia Schwalm
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.24 | | | | | |
| Relative Return to S&P 500(%) | 16.02 | | | | | |
Cynthia Schwalm Ownership Network
Ownership Network List of Cynthia Schwalm
Ownership Network Relation of Cynthia Schwalm
Cynthia Schwalm Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Cynthia Schwalm is the director of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Cynthia Schwalm made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Cynthia Schwalm Mailing Address
Above is the net worth, insider trading, and ownership report for Cynthia Schwalm. You might contact Cynthia Schwalm via mailing address: C/o G1 Therapeutics, 700 Park Offices Dr, Suite 200, P.o. Box 110341, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
